CD10+ PSCs produced higher amounts of matrix metalloproteinase 3 (MMP3) than CD10− PSCs, whose siRNA-based knockdown attenuated the invasive capacity of the pancreatic cancer cells (Ikenaga et al., 2010). Here, MMP3 is linked to pancreatic neoplasm.